Weekly Semaglutide Injections: How Often Do You Take Semaglutide Shots for Effective Weight Loss?

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Injectable semaglutide is a once-weekly medication. That is a labeled property of the product rather than a preference — both Wegovy and Ozempic are dosed once weekly, and the molecule was engineered specifically to make that interval possible. What is not a general answer is which strength you should be on, how quickly you move between strengths, or what to do when a step is not tolerated. Those are prescriber decisions recorded on your pharmacy label, and this article explains why rather than substituting for them.

Why Once Weekly Works Pharmacologically

Native GLP-1 is degraded by dipeptidyl peptidase-4 within minutes of release. Semaglutide is structurally modified to resist that degradation and to bind reversibly to albumin, which slows renal clearance and extends its duration of action dramatically.

The result is a circulating half-life long enough that steady-state exposure is maintained across a seven-day interval. That is the entire design goal: a stable concentration rather than a daily peak and trough.

Oral semaglutide is a different problem with a different solution. Rybelsus and Ozempic tablets are taken daily because absorption across the gastric mucosa requires an absorption enhancer and delivers far less of each dose into circulation. The two routes are not interchangeable on a milligram-to-milligram basis, and the label says so explicitly.

Timing Flexibility, and Its Limits

The labeling permits the day of weekly administration to be changed if necessary, provided at least 2 days — more than 48 hours — separate two doses. Tirzepatide labeling uses a longer interval, requiring at least 72 hours between doses when the day is changed.

There is no circadian or meal-timing requirement for the injectable products. The labels permit administration at any time of day, with or without meals. Claims that morning dosing or bedtime dosing improves results are not supported by the labeling.

What the label does not do is authorise you to reschedule on your own initiative. The reason is not that the pharmacology is fragile — it is that missed-dose and rescheduling handling is product-specific and is written for the prescriber and the pharmacy label, which is where your answer should come from.

The Escalation Exists for Tolerability

The Wegovy label contains a stepwise escalation from a low starting strength toward a maintenance strength. Its purpose is to reduce gastrointestinal adverse reactions — nausea, vomiting, diarrhea, abdominal pain and constipation are the most common adverse reactions in this class and the most common reason people stop.

Labeled injection strengths are 0.25, 0.5, 1, 1.7 and 2.4 mg, with Wegovy HD at 7.2 mg approved March 19, 2026. Presentations include single-dose pens, single-dose syringes, and a single-patient-use Wegovy FlexTouch pen containing 9.6 mg/3 mL that delivers four 2.4 mg doses.

That last presentation is newer than most published summaries. The 06/2026 revision of the label added it along with a warning section directing that the FlexTouch pen never be shared between patients. Anything you read stating Wegovy comes only in single-dose pens is out of date.

Weekly Consistency Is What the Trials Measured

STEP 1 ran 68 weeks in 1,961 adults with once-weekly dosing throughout and reported a mean body weight change of −14.9% versus −2.4% with placebo. Study 8 in the Wegovy label ran 72 weeks in 1,407 participants and reported −18.8% at 7.2 mg and −15.5% at 2.4 mg versus −3.9%.

Those results describe sustained weekly administration over more than a year. They do not describe intermittent use, and there is no evidence base for a cycled or as-needed schedule in weight management.

Interruption behaves like discontinuation. Randomised withdrawal trials across the class show substantial weight regain after stopping, which is why continuity of supply and coverage is a clinical issue rather than an administrative one.

Practical Handling Belongs to the Label and the Pharmacy

Storage, needle handling, injection site selection, what to do about a missed dose and how to recognise a device fault are all documented in the instructions for use that ship with your specific product. They differ between presentations — a single-dose pen and a multi-dose FlexTouch pen are not handled the same way.

The FDA has received complaints that compounded GLP-1 drugs arrived warm or with inadequate ice packs, and recommends that patients not use any injectable GLP-1 drug that arrives warm or insufficiently refrigerated. Injectable GLP-1 products require refrigeration as stated in their package inserts.

If your instructions for use are missing or damaged, that is itself a red flag the FDA lists among its telehealth warning signs. Contact the dispensing pharmacy rather than substituting guidance found online.

Questions Worth Asking at Your Next Visit

Which product am I on, and does it hold a weight-management indication? What strength am I at, and what triggers a change? Which symptoms warrant a call rather than waiting?

How will we decide when I have reached maintenance? What is the plan if a step is not tolerated? And what does long-term look like, given that the indication itself includes maintaining weight reduction long term?

Those questions produce a plan specific to you. A schedule copied from a general article does not, because it carries none of the context that makes a schedule safe.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How often is injectable semaglutide taken?

Once weekly. Both Wegovy and Ozempic are once-weekly subcutaneous injections, and the molecule was engineered specifically to support that interval through resistance to enzymatic degradation and reversible albumin binding. Oral semaglutide products — Rybelsus, Ozempic tablets and Wegovy tablets — are taken daily instead, because absorption by that route works differently.

Can the injection day be changed?

The labeling permits the day of weekly administration to be changed if necessary, provided at least 2 days — more than 48 hours — separate two doses. Tirzepatide labeling requires at least 72 hours. That is a labeled property, not a licence to reschedule independently: confirm any change with your prescriber, who is managing the whole regimen.

Does the time of day matter?

For the injectable products, no. The labels permit administration at any time of day, with or without meals, and there is no circadian or meal-timing requirement. Claims that morning or evening dosing improves results are not supported by the labeling. Oral semaglutide products have their own specific administration directions that do matter and appear on the pharmacy label.

Why does the strength increase over time?

To limit gastrointestinal adverse reactions. Nausea, vomiting, diarrhea, abdominal pain and constipation are the most common adverse reactions in this class and the most common reason for discontinuation. Starting at a low strength and escalating stepwise reduces those symptoms compared with beginning at a maintenance strength. The pace of escalation is a prescriber decision.

What if I miss a weekly dose?

That answer is product-specific and belongs to your pharmacy label and your prescriber rather than to a general article. The instructions for use shipped with your particular presentation address it directly, and the correct action depends on how much time has elapsed and which product you hold. Contact the dispensing pharmacy or your prescriber for guidance.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.